Increased levels of plasma tissue factor pathway inhibitor in patients with glioblastoma and intracerebral metastases

Neurological Research

Volumn 25, Issue 4, 2003, Pages 335-338

  Gerlach, Rüdiger ^a   Scheuer, Timm ^a   Böhm, Martina ^a   Beck, Jürgen ^a   Woszczyk, Alina ^a   Raabe, Andreas ^a   Scharrer, Inge ^a   Seifert, Volker ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Craniotomy; Neoplasm; Neurosurgical procedure; Serine proteinase inhibitors; TFPI

Indexed keywords

ANTIGEN; TISSUE FACTOR PATHWAY INHIBITOR;

ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN METASTASIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GLIOBLASTOMA; HEMANGIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HYPOPHYSIS TUMOR; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; NEURINOMA; OLIGODENDROGLIOMA; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE;

ADULT; AGED; ASTROCYTOMA; BRAIN NEOPLASMS; FEMALE; GLIOBLASTOMA; HEMANGIOBLASTOMA; HUMANS; LIPOPROTEINS; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; NEURILEMMOMA; OLIGODENDROGLIOMA; PITUITARY NEOPLASMS;

EID: 0037677673     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164103101201652     Document Type: Article

References (23)

1. Bajaj MS, Birktoft JJ, Steer SA, Bajaj SP. Structure and biology of tissue factor pathway inhibitor. Thromb Haemost 2001; 86: 959-972
2. Iversen N, Lindahl AK, Abildgaard U. Elevated TFPI in malignant disease: Relation to cancer type and hypercoagulation. Br J Haematol 1998; 102: 889-895
3. Iversen N, Lindahl AK, Abildgaard U. Elevated plasma levels of the factor Xa-TFPI complex in cancer patients. Thromb Res 2002; 105: 33-36
4. Hamada K, Kuratsu J, Saitoh Y, Takeshima H, Nishi T, Ushio Y. Expression of tissue factor in glioma. Noshuyo Byori 1996; 13: 115-118
5. Hamada K, Kuratsu J, Saitoh Y, Takeshima H, Nishi T, Ushio Y. Expression of tissue factor correlates with grade of malignancy in human glioma. Cancer 1996; 77: 1877-1883
6. Guan M, Su B, Lu Y. Quantitative reverse transcription-PCR measurement of tissue factor mRNA in glioma. Mol Biotechnol 2002; 20: 123-129
7. Osterud B, Bajaj MS, Bajaj SP. Sites of tissue factor pathway inhibitor (TFPI) and tissue factor expression under physiologic and pathologic conditions. On behalf of the Subcommittee on Tissue factor Pathway Inhibitor (TFPI) of the Scientific and Standardization Committee of the ISTH. Thromb Haemost 1995; 73: 873-875
8. Bromberg ME, Konigsberg WH, Madison JF, Pawashe A, Garen A. Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation. Proc Natl Acad Sci USA 1995; 92: 8205-8209
9. Fischer EG, Riewald M, Huang HY, Miyagi Y, Kubota Y, Mueller BM, Ruf W. Tumor cell adhesion and migration supported by interaction of a receptor-protease complex with its inhibitor. J Clin Invest 1999; 104: 1213-1221
10. Rao CN, Gomez DE, Woodley DT, Thorgeirsson UP. Partial characterization of novel serine proteinase inhibitors from human umbilical vein endothelial cells. Arch Biochem Biophys 1995; 319: 55-62
11. Carmeliet P, Mackman N, Moons L, Luther T, Gressens P, Van VI, Demunck H, Kasper M, Breier G, Evrard P, Muller M, Risau W, Edgington T, Collen D. Role of tissue factor in embryonic blood vessel development. Nature 1996; 383: 73-75
12. Zhang Y, Deng Y, Luther T, Muller M, Ziegler R, Waldherr R, Stern DM, Nawroth PP. Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J Clin Invest 1994; 94: 1320-1327
13. Sawaya R, Zuccarello M, Elkalliny M, Nishiyama H. Postoperative venous thromboembolism and brain tumors: Part I. Clinical profile. J NeuroOncol 1992; 14: 119-125
14. Thoron L, Arbit E. Hemostatic changes in patients with brain tumors. J NeuroOncol 1994; 22: 87-100
15. Hamilton MG, Hull RD, Pineo GF. Venous thromboembolism in neurosurgery and neurology patients: A review. Neurosurgery 1994; 34: 280-296
16. Lindahl AK, Sandset PM, Abildgaard U. Indices of hypercoagulation in cancer as compared with those in acute inflammation and acute infarction. Haemostasis 1990; 20: 253-262
17. Rao LV. Tissue factor as a tumor procoagulant. Cancer Metastasis Rev 1992; 11: 249-266
18. Werling RW, Zacharski LR, Kisiel W, Bajaj SP, Memoli VA, Rousseau SM. Distribution of tissue factor pathway inhibitor in normal and malignant human tissues. Thromb Haemost 1993; 69: 366-369
19. Callander NS, Varki N, Rao LV. Immunohistochemical identification of tissue factor in solid tumors. Cancer 1992; 70: 1194-1201
20. Kakkar AK, DeRuvo N, Chinswangwatanakul V, Tebbutt S, Williamson RC. Extrinsic-pathway activation in cancer with high factor VIIa and tissue factor. Lancet 1995; 346: 1004-1005
21. Amini-Nekoo A, Futers TS, Moia M, Mannucci PM, Grant PJ, Ariens RA. Analysis of the tissue factor pathway inhibitor gene and antigen levels in relation to venous thrombosis. Br J Haematol 2001; 113: 537-543
22. Broze GJ Jr, Lange GW, Duffin KL, MacPhail L. Heterogeneity of plasma tissue factor pathway inhibitor. Blood Coag Fibrinolysis 1994; 5: 551-559
23. Bajaj, MS, Ameri A, Bajaj SP. Tissue factor pathway inhibitor - A regulator of tissue factor-induced coagulation. In: Green D, ed. Anticoagulants: Physiologic, Pathologic and Pharmacologic, Florida: CRC Press, 1994: pp. 41-65